{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:19:59Z","timestamp":1793233199954,"version":"4.5.0"},"reference-count":13,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,5,5]]},"abstract":"<jats:p>A 17-year-old female with recently relapsed acute lymphoblastic leukaemia and a treatment course complicated by rhinocerebral mucormycosis infection developed severe peripheral neuropathy during the treatment for mucormycosis infection. This was felt to be a medication side effect. Her peripheral neuropathy was refractory to many well-established treatments, but ultimately responded dramatically and consistently to a novel therapy, topical doxepin cream (5%). This case report is the first published report of the application of topical doxepin cream for treatment of peripheral neuropathy in a paediatric patient.<\/jats:p>","DOI":"10.1136\/bcr-2017-219900","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T23:45:25Z","timestamp":1495496725000},"page":"bcr-2017-219900","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Severe medication-induced peripheral neuropathy treated with topical doxepin cream in a paediatric patient with leukaemia"],"prefix":"10.1136","volume":"2017","author":[{"given":"Zephyr D","family":"Dworsky","sequence":"first","affiliation":[{"name":"Pediatrics, University of California, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bennett","sequence":"additional","affiliation":[{"name":"Acute\/Chronic Pain Service, Rady Children's Hospital - San Diego, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny M","family":"Kim","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology, University of California, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4154-0057","authenticated-orcid":false,"given":"Dennis John","family":"Kuo","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology, University of California, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2012.02.011"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.2","first-page":"CD007115","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","volume":"1","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c6100"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr233"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/papr.12312","article-title":"Hyperbaric oxygen therapy: a new treatment for chronic pain?","volume":"16","author":"Sutherland","year":"2016","journal-title":"Pain Pract"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2009.11.010"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.7","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31821f9544"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.8","doi-asserted-by":"publisher","DOI":"10.1002\/j.1532-2149.2012.00113.x"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1155\/2013\/147043","article-title":"Effects of hyperbaric oxygen on pain-related behaviors and nitric oxide synthase in a rat model of neuropathic pain","volume":"18","author":"Han","year":"2013","journal-title":"Pain Res Manag"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.10","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-013-0213-3"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.11","first-page":"355","article-title":"The effectiveness of intermittent hyperbaric oxygen in relieving drug-induced HIV-associated neuropathy","volume":"90","author":"Jordan","year":"1998","journal-title":"J Natl Med Assoc"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.12","doi-asserted-by":"publisher","DOI":"10.1163\/156856900750228097"},{"key":"2025082723444132000_2017.may17_1.bcr-2017-219900.13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2125.2000.00200.x","article-title":"Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study","volume":"49","author":"McCleane","year":"2001","journal-title":"Br J Clin Pharmacol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-219900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:44:49Z","timestamp":1756363489000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-219900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":13,"alternative-id":["10.1136\/bcr-2017-219900"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-219900","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]}}}